Cargando…
Parkinson’s disease and COVID-19: a systematic review and meta-analysis
BACKGROUND: Patients with Parkinson’s disease (PD) are at higher risk of COVID-19 infection as most of them are at older age. The goal of this study is to update the pooled prevalence of COVID-19 infection in patients with PD. METHODS: Two researchers systematically searched PubMed, Scopus, EMBASE,...
Autores principales: | Khoshnood, Reza Jalili, Zali, Alireza, Tafreshinejad, Arash, Ghajarzadeh, Mahsa, Ebrahimi, Narges, Safari, Saeid, Mirmosayyeb, Omid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596358/ https://www.ncbi.nlm.nih.gov/pubmed/34787753 http://dx.doi.org/10.1007/s10072-021-05756-4 |
Ejemplares similares
-
Correction to: Parkinson’s disease and COVID‑19: a systematic review and meta‑analysis
por: Khoshnood, Reza Jalili, et al.
Publicado: (2021) -
The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2021) -
COVID-19 vaccines and patients with multiple sclerosis: willingness, unwillingness and hesitancy: a systematic review and meta-analysis
por: Yazdani, Amid, et al.
Publicado: (2022) -
Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage
por: Shaygannejad, Vahid, et al.
Publicado: (2021) -
COVID-19-related strokes in adults below 55 years of age: a case series
por: Ashrafi, Farzad, et al.
Publicado: (2020)